RNA Clinical Trials Solutions

1. Toxicology Support: Regulatory Strategy And Submission Support 12/2/2025

   Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.

2. Pharmacometric Services 6/27/2023

   Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.

3. Clinical And Regulatory Strategy 11/7/2023

   Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.

4. Earn The Trust Of Biotechs And Emerging Pharma 12/10/2025

   Backed by a global team of more than 3,000 professionals across 34 office locations, we deliver scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.

5. Clinical Operations And Project Management For Every Phase 12/21/2022

   Get streamlined and integrated clinical trial services delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development. 

6. Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies 10/19/2022

   Stay on top of changes in the ever-evolving world of cell and gene therapies and more. Our in-house subject matter experts comb through the data weekly to ensure we provide you with the most current and comprehensive information important to this market.

7. Novotech Laboratory Services 11/7/2023

   Our bioanalytical services assist our customers in every stage of their molecule development.

8. Orphan And Rare Disease CRO Services 11/7/2023

   Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.

9. New Next-Generation GMP Facility 5/16/2023

   A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.

10. Infectious Diseases And Vaccines CRO Services 6/27/2023

    Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.